Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 2931 KiB)
Baraibar, I.; Roman, M.; Rodríguez-Remírez, M.; López, I.; Vilalta, A.; Guruceaga, E.; Ecay, M.; Collantes, M.; Lozano, T.; Alignani, D.; Puyalto, A.; Oliver, A.; Ortiz-Espinosa, S.; Moreno, H.; Torregrosa, M.; Rolfo, C.; Caglevic, C.; García-Ros, D.; Villalba-Esparza, M.; De Andrea, C.; Vicent, S.; Pío, R.; Lasarte, J.J.; Calvo, A.; Ajona, D.; Gil-Bazo, I. Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers 2020, 12, 3169. https://doi.org/10.3390/cancers12113169
Baraibar I, Roman M, Rodríguez-Remírez M, López I, Vilalta A, Guruceaga E, Ecay M, Collantes M, Lozano T, Alignani D, Puyalto A, Oliver A, Ortiz-Espinosa S, Moreno H, Torregrosa M, Rolfo C, Caglevic C, García-Ros D, Villalba-Esparza M, De Andrea C, Vicent S, Pío R, Lasarte JJ, Calvo A, Ajona D, Gil-Bazo I. Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers. 2020; 12(11):3169. https://doi.org/10.3390/cancers12113169
Chicago/Turabian StyleBaraibar, Iosune, Marta Roman, María Rodríguez-Remírez, Inés López, Anna Vilalta, Elisabeth Guruceaga, Margarita Ecay, María Collantes, Teresa Lozano, Diego Alignani, Ander Puyalto, Ana Oliver, Sergio Ortiz-Espinosa, Haritz Moreno, María Torregrosa, Christian Rolfo, Christian Caglevic, David García-Ros, María Villalba-Esparza, Carlos De Andrea, Silvestre Vicent, Rubén Pío, Juan José Lasarte, Alfonso Calvo, Daniel Ajona, and Ignacio Gil-Bazo. 2020. "Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells" Cancers 12, no. 11: 3169. https://doi.org/10.3390/cancers12113169